For patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) admitted to the intensive care unit ...
Protein-calorie malnutrition in patients with COPD exacerbation is linked to higher risk for mortality, AKI, respiratory ...
Adults with COPD receiving roflumilast had a smaller COPD exacerbation rate at 1 year vs. those receiving azithromycin but ...
Anti-IL5 therapy significantly reduces moderate and severe exacerbations in asthma and COPD, preventing major ...
Ensifentrine significantly improved lung function after 12 weeks in patients with moderate to severe COPD with and without ...
RedChip Companies will host an investor webinar with Connect Biopharma Holdings Limited (Nasdaq:CNTB) (Connect Biopharma, ...
In bronchiectasis, highly symptomatic patients have a greater risk of exacerbations and may benefit from long-term macrolide treatment.
Among adults with COPD and type 2 inflammation, having a history of cardiovascular or metabolic disease did not change ...
In a 24-week post hoc ENHANCE analysis, ensifentrine improved symptoms, dyspnea, and quality of life for stable COPD patients ...
New findings from the ERS Global Congress on Lung Diseases present a paradigm shift in COPD treatment: Early identification of type 2 inflammation and personalized biologic therapy.
Dedicated COPD respiratory therapists can improve inhaler use, ensure adherence, and bridge care transitions, explained Megan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback